| Literature DB >> 30501676 |
M C Rota1, A Bella1, M G Caporali1, A Nicolau2, V Drasar3, M L Ricci1, M Scaturro1, M Gumá2, S Crespi4.
Abstract
According to European Guidelines for Legionnaires' Disease prevention and control, travel-associated Legionnaires' disease (TALD) cases are managed differently if classified as sporadic or as part of a cluster and more stringent control measures are deployed after clusters are identified. In this study, we propose to modify the current cluster definition: 'two or more cases of Legionnaires' disease (LD) who stayed at, or visited, the same commercial accommodation site 2-10 days before onset of illness and whose onset is within the same 2-year period' with a new cluster definition, i.e. accommodation sites associated with multiple cases regardless of the time elapsed between them. TALD cases occurred in Italy and in the Balearic Islands between 2005 and 2015 were analysed applying the current European Legionnaires' Disease Surveillance Network (ELDSNet) cluster definition. In a sample of selected accommodation sites with multiple cases, a microbiological study was also conducted. Using the new definition, 63 additional sites (16.4% increase) and 225 additional linked cases (19.5% increase) were identified. Legionella pneumophila sg1 was isolated from 90.7% of the selected accommodation sites. The use of the here proposed TALD cluster definition would warrant a full investigation for each new identified case. This approach should therefore increase the number of sites that will require a risk assessment and, in the presence of an increased risk, the adoption of LD control measures to hopefully prevent additional cases.Entities:
Keywords: Accommodation site; Legionnaires' disease cluster; TALD
Year: 2018 PMID: 30501676 PMCID: PMC6518564 DOI: 10.1017/S0950268818003266
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
European definitions for single case, cluster and re-offending site and newly proposed cluster definition
| Single-case definition | Cluster definition | Reoffending sites | Newly proposed cluster definition |
|---|---|---|---|
| According to ELDSNet | |||
| Cases who in the 2–10 days before onset of illness stayed at or visited a commercial accommodation site that has not been associated with any other cases of LD, or cases who stayed at an accommodation site linked to other cases of LD more than 2 years previously | Two or more cases who stayed at or visited the same commercial accommodation site in the 2–10 days before onset of illness and whose onset is within the same 2-year period | Sites associated with clusters investigated by the Network that were associated with at least one further case in a 2-year period | Sites associated with at least two cases regardless of the time elapsed between them |
TALD cases and accommodation sites reported in Italy and Balearic Islands in 2005–2015
| Definition | Italy, | Balearic Islands, | Total | |
|---|---|---|---|---|
| Current ELDSNet definition | TALD cases | 2686 | 235 | 2921 |
| Number of accommodation sites | 1813 | 169 | 1982 | |
| Single cases | 1616/2686 (60.1) | 154/235 (65.5) | 1770/2921 (60.6) | |
| Cluster sites | 358 | 27 | 385 | |
| Cluster cases | 1070/2686 (39.9) | 81/235 (34.5) | 1151/2921 (39.4) | |
| Reoffending sites | 84/358 (23.5) | 5/27 (18.5) | 89/385 (23.1) | |
| Cases associated with reoffending sites | 345/1070 (32.2) | 8/81 (9.8) | 353/1151 (30.6) | |
| New proposed cluster definition | Cluster sites | 418 | 30 | 448 |
| Cluster cases | 1280 | 96 | 1376 |
According to the definition in Ricketts et al. (2010).
Fig. 1.Number of accommodation sites and cases associated with clusters according the current ELDSNet cluster definition and to the new proposed definition.
Typing of environmental and clinical strains isolated from 54 accommodation sites with recurrent cases in 2005–2015
| Site | Serogroup | Mab 3/1 | ST (environmental) | ST (clinical) | ||
|---|---|---|---|---|---|---|
| 1 | 6 | NA | NA | NA | ||
| 2 | 1 | Pos | 42 | NA | ||
| 3 | 1, 5, 8 | Neg | 1 | NA | ||
| 4 | 1 | Pos | 1584 | NA | ||
| 5 | 1 | NA | NA | NA | ||
| 6 | 1 | NA | NA | NA | ||
| 7 | 1 | Pos | NA | NA | ||
| 8 | 1, 6 | Neg | 1 | NA | ||
| 9 | 1, 6 | Pos | NA | NA | ||
| 10 | 1 | Pos | NA | NA | ||
| 11 | 1 | Pos | NA | NA | ||
| 12 | 1 | NA | NA | NA | ||
| 13 | 1, 5 | Neg | 1 | NA | ||
| 14 | 1 | Pos | 23 | NA | ||
| 15 | 1 | Pos | 42 | 42 | ||
| 16 | 1 | Pos | 885 | 885 | ||
| 17 | 1 | Pos | 23 | 23 | ||
| 18 | 1, 5, 3 | Neg | NA | 47, 146 | ||
| 19 | 1, 6 | Pos | Novel | NA | ||
| 20 | NA | NA | NA | |||
| 21 | 1 | Pos | 616 | 616 | ||
| 22 | 1 | NA | NA | NA | ||
| 23 | 1 | Pos | 42, 1 | 42 | ||
| 24 | 1, 3 | Neg | NA | NA | ||
| 25 | 1 | Pos | 1 | 1 (×2) | ||
| 26 | 1 | Pos | 1090 | 1090 (×2) | ||
| 27 | 1 | Pos | 20 | 20(×2) | ||
| 28 | 1, 6 | Pos | 146, 2156, 435 | 2156, 435 | ||
| 29 | 1, 5 | Neg | NA | NA | ||
| 30 | 1 | NA | NA | NA | ||
| 31 | 1 | NA | NA | NA | ||
| 32 | 1 | NA | NA | NA | ||
| 33 | 1 | Pos | 1 | NA | ||
| 34 | 1 | NA | NA | NA | ||
| 35 | 1, 6 | NA | NA | NA | ||
| 36 | 1 | NA | NA | Clinical strain available, SBT not performed | ||
| 37 | 1 | Pos | NA | NA | ||
| 38 | 2–14 | Pos | NA | NA | ||
| 39 | NA | NA | NA | |||
| 40 | 1, 8, 10 | Pos | NA | NA | ||
| 41 | 1 | NA | NA | NA | ||
| 42 | 1 | NA | NA | NA | ||
| 43 | 1 | NA | NA | NA | ||
| 44 | 1 | Pos | 23 | 23 | ||
| 45 | NA | NA | NA | |||
| 46 | 1 | NA | NA | NA | ||
| 47 | 1 | NA | NA | NA | ||
| 48 | 1 | Pos | NA | NA | ||
| 49 | 1 | Pos | NA | NA | ||
| 50 | 1 | NA | NA | NA | ||
| 51 | 1 | NA | NA | 23 | ||
| 52 | 1 | Pos | 901 | NA | ||
| 53 | 1 | Pos | 901 | NA | ||
| 54 | 1 | Pos | 182 | NA | ||
(×2) means that two undistinguishable strains were isolated in different years in the same accommodation site.